- Home
- CNTX vs LPTH Comparison
CNTX vs LPTH Comparison
Compare CNTX & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- LPTH
- Stock Information
- Founded
- CNTX 2015
- LPTH 1985
- Country
- CNTX United States
- LPTH United States
- Employees
- CNTX N/A
- LPTH N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- LPTH Semiconductors
- Sector
- CNTX Health Care
- LPTH Technology
- Exchange
- CNTX Nasdaq
- LPTH Nasdaq
- Market Cap
- CNTX 78.0M
- LPTH 81.1M
- IPO Year
- CNTX 2021
- LPTH 1996
- Fundamental
- Price
- CNTX $0.58
- LPTH $2.88
- Analyst Decision
- CNTX Strong Buy
- LPTH Strong Buy
- Analyst Count
- CNTX 4
- LPTH 3
- Target Price
- CNTX $6.00
- LPTH $4.67
- AVG Volume (30 Days)
- CNTX 164.6K
- LPTH 167.9K
- Earning Date
- CNTX 05-07-2025
- LPTH 05-15-2025
- Dividend Yield
- CNTX N/A
- LPTH N/A
- EPS Growth
- CNTX N/A
- LPTH N/A
- EPS
- CNTX N/A
- LPTH N/A
- Revenue
- CNTX N/A
- LPTH $33,626,969.00
- Revenue This Year
- CNTX N/A
- LPTH $16.90
- Revenue Next Year
- CNTX N/A
- LPTH $52.77
- P/E Ratio
- CNTX N/A
- LPTH N/A
- Revenue Growth
- CNTX N/A
- LPTH 2.59
- 52 Week Low
- CNTX $0.49
- LPTH $1.04
- 52 Week High
- CNTX $2.75
- LPTH $4.42
- Technical
- Relative Strength Index (RSI)
- CNTX 33.91
- LPTH 64.02
- Support Level
- CNTX $0.49
- LPTH $2.28
- Resistance Level
- CNTX $0.71
- LPTH $3.08
- Average True Range (ATR)
- CNTX 0.08
- LPTH 0.19
- MACD
- CNTX -0.02
- LPTH 0.03
- Stochastic Oscillator
- CNTX 33.31
- LPTH 75.86
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.